Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$215.4MMiss by $5.5M
EPS$0.55Miss by $0.21
Revenue estimate$220.8M
EPS estimate$0.76

Next report

Aug 4, 2026 (In 5 days)
Revenue estimate$249.0M
EPS estimate$0.97

Financials

Q1 2026

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$2.08B+1.5%
Enterprise value$1.66B-1.2%
P/E14.3×+3.0×
P/S2.3×-0.3×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Segments

By segment

See full
Rare Neurological Diseases$215.4M+16.6%

Versus estimates

Revenue

Q1 2026$215.4MMiss by $5.5M
Q4 2025$243.8MBeat by $3.5MQ3 2025$239.5MMiss by $581.2KQ2 2025$200.5MMiss by $19.7MQ1 2025$184.7MMiss by $21.3MQ4 2024$201.3MBeat by $18.1M

Diluted EPS

Q1 2026$0.55Miss by $0.21
Q4 2025$0.38Miss by $0.46Q3 2025$0.87Miss by $0.05Q2 2025$0.68Miss by $0.10Q1 2025$0.78Beat by $0.19Q4 2024$0.85Beat by $0.11

Ask the moment Harmony Biosciences Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Harmony Biosciences Holdings, Inc. report Q1 2026 earnings?
Harmony Biosciences Holdings, Inc. (HRMY) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Harmony Biosciences Holdings, Inc.'s Q1 2026 revenue and EPS?
Harmony Biosciences Holdings, Inc. reported revenue of $215.4M and eps of $0.55 for Q1 2026.
Did Harmony Biosciences Holdings, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $220.8M by $5.5M. EPS missed the consensus estimate of $0.76 by $0.21.
How did Harmony Biosciences Holdings, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.6% from $184.7M a year earlier and eps declined 29.5% from $0.78.
Where can I find Harmony Biosciences Holdings, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-056786) and the 10-Q periodic report (0001104659-26-056720) directly on SEC EDGAR. The filing index links above go to sec.gov.